EGFR-IN-95
EGFR-IN-95 (compound 5j) is an 2,4-diaminonicotinamide derivative. EGFR-IN-95 has potent inhibitory activity against EGFR del19/T790M/C797S and L858R/T790M/C797S[1].
Product Specifications
CAS Number
3027135-04-9
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfr-in-95.html
Purity
98.76
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(C=C(N=C1)NC2=CC=NC(C3=CN(N=C3)S(=O)(C4CC4)=O)=N2)N[C@H](CC)C)NCCC(F)F
Molecular Formula
C23H28F2N8O3S
Molecular Weight
534.58
References & Citations
[1]Hideaki Kageji, et al. Synthesis, activity, and their relationships of 2,4-diaminonicotinamide derivatives as EGFR inhibitors targeting C797S mutation. Bioorg Med Chem Lett. 2023.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882593-100 1x 100 µL
Cyclin D1 (G1-Cyclin & Mantle Cell Lymphoma Marker) (CCND1/2593), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
K2087003 1.0 µg DNA
SAMD5 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details A04136-1-iFluor647 100 µg
Anti-p23/PTGES3 Antibody Picoband®, iFluor647 Conjugate
Sign In for Pricing
View Details 
bsm-61634R-Cy7-01 20 µL
Insulin Receptor R Recombinant Antibody, Cy7 Conjugated
Sign In for Pricing
View Details bsm-61634R-Cy7-02 100 µL
Insulin Receptor R Recombinant Antibody, Cy7 Conjugated
Sign In for Pricing
View Details 